Literature DB >> 11450843

Clinical and genetic features of nonsyndromic autosomal dominant sensorineural hearing loss: KCNQ4 is a gene responsible in Japanese.

J Akita1, S Abe, H Shinkawa, W J Kimberling, S Usami.   

Abstract

Sixteen Japanese nonsyndromic autosomal dominant sensorineural hearing loss (ADSNHL) families were investigated clinically as well as genetically. Most families showed postlingual hearing loss. Although the severity of their hearing loss varied, most patients showed mild-moderate sensorineural hearing loss of a progressive nature. Mutation analysis was performed for the MYO7A, KCNQ4, and GJB3 genes, which are known to be responsible for autosomal dominant sensorineural hearing loss. The present study reports that a mutation in KCNQ4, a member of a large family of potassium channel genes, was responsible for ADSNHL in one Japanese family.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450843     DOI: 10.1007/s100380170053

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

1.  Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers.

Authors:  Michael G Leitner; Anja Feuer; Olga Ebers; Daniela N Schreiber; Christian R Halaszovich; Dominik Oliver
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  KCNQ potassium channels in sensory system and neural circuits.

Authors:  Jing-jing Wang; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2015-12-21       Impact factor: 6.150

3.  Cellular and molecular mechanisms of autosomal dominant form of progressive hearing loss, DFNA2.

Authors:  Hyo Jeong Kim; Ping Lv; Choong-Ryoul Sihn; Ebenezer N Yamoah
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

4.  A novel KCNQ4 one-base deletion in a large pedigree with hearing loss: implication for the genotype-phenotype correlation.

Authors:  Fumiaki Kamada; Shigeo Kure; Takayuki Kudo; Yoichi Suzuki; Takeshi Oshima; Akiko Ichinohe; Kanako Kojima; Tetsuya Niihori; Junko Kanno; Yoko Narumi; Ayumi Narisawa; Kumi Kato; Yoko Aoki; Katsuhisa Ikeda; Toshimitsu Kobayashi; Yoichi Matsubara
Journal:  J Hum Genet       Date:  2006-04-05       Impact factor: 3.172

Review 5.  KV7 channelopathies.

Authors:  Snezana Maljevic; Thomas V Wuttke; Guiscard Seebohm; Holger Lerche
Journal:  Pflugers Arch       Date:  2010-04-18       Impact factor: 3.657

6.  A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression.

Authors:  Angeles Mencía; Daniel González-Nieto; Silvia Modamio-Høybjør; Ainhoa Etxeberría; Gracia Aránguez; Nieves Salvador; Ignacio Del Castillo; Alvaro Villarroel; Felipe Moreno; Luis Barrio; Miguel Angel Moreno-Pelayo
Journal:  Hum Genet       Date:  2007-11-21       Impact factor: 4.132

Review 7.  KCNQ4 mutations associated with nonsyndromic progressive sensorineural hearing loss.

Authors:  Liping Nie
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 2.064

Review 8.  Vestibular function in families with inherited autosomal dominant hearing loss.

Authors:  Valerie A Street; Jeremy C Kallman; Paul D Strombom; Naomi F Bramhall; James O Phillips
Journal:  J Vestib Res       Date:  2008       Impact factor: 2.435

9.  Association of TMTC2 With Human Nonsyndromic Sensorineural Hearing Loss.

Authors:  Christina L Runge; Amit Indap; Yifan Zhou; Jack W Kent; Ericka King; Christy B Erbe; Regina Cole; Jack Littrell; Kate Merath; Roland James; Franz Rüschendorf; Joseph E Kerschner; Gabor Marth; Norbert Hübner; Harald H H Göring; David R Friedland; Wai-Meng Kwok; Michael Olivier
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-09-01       Impact factor: 6.223

10.  Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locus.

Authors:  Michael S Hildebrand; Dylan Tack; Sarah J McMordie; Adam DeLuca; In Ae Hur; Carla Nishimura; Patrick Huygen; Thomas L Casavant; Richard J H Smith
Journal:  Genet Med       Date:  2008-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.